top of page

GN Clinic

GN_photo_Clinical6_0001.jpg

Overview

Lupus nephritis, ANCA associated vasculitis, Membranous nephropathy, FSGS (primary, secondary, genetic), Minimal change disease, Fibrilliary GN, IgA nephropathy, MPGN, C3 glomerulonephritis, Dense deposit disease, Hereditary nephritis, PGNMID, Anti-GBM disease, Cryoglobulinemic GN

For systemic diseases we work closely with rheumatologist. We also work clsoely with geneticists and provide a wide array of genetic testing.

200 First Street SW
Rochester, MN
55905

Kathy Hegna Zelinske
zelinske.kathleen@mayo.edu
507-266-1044

Director

Fernando Fervenza, M.D.

Ladan Zand, M.D.
Eddie Greene, M.D.
Steven Erickson, M.D.
Marie Hogan, M.D.

Neuropathologists

Sanjeev Sethi, M.D.
Lynn Cornell, M.D.
Priya Alexander, M.D.
Samih Nasr, M.D.
Loren Herrera, M.D.

Current active clinical trials:

Daratumumab in lupus nephritis
Obinutuzumab in primary FSGS
Daratumumab in PGNMID
trials in IgA nephropathy (sibeprenlimab)

Current non-trial studies

N/A

Accepting trainee applications?

Yes – GN fellows and research trainees

bottom of page